swish30

swish30

Just a snapshot of the 10y interest rate

swish30

Strong earnings release with revenue growing at 100% yoy, earnings still negative. Has overshot the 50% fib level. Previous support at around $6 per share, dip buying around that area could be a reasonable trade.

swish30

Record revenues realised and loss per share came in. Good result, stock opened a bit too strongly and took the entire day to find support. Potential bounce today.

swish30

Usually clinical data isn't super positive on day 2 but these guys recently raised money, Point72 bought into the company. Almost no shares to short out there. Today I expect this to trade around 2.15 in decent size. Looking to buy on dips for instant profit and potentially hold some for a run up to $3

swish30

Positive P2 clinical trial data came out on a similar product that failed P3 trials earlier in the year rendering the company almost worthless. Spiked to its cash balance after market. There's potential for this to spike higher a bit like ONCS if ppl think the company has hope. Potential trades: Buy pre-market for a morning spike in the 7-8 range Dip buy a...

swish30

finance.yahoo.com At current run rate company is pulling in 500m in revenue growing at 50%. Prob trades at 5x P/S, a price of $25 per share today given that this is hugely hyped up. So much hype already though, best risk reward is on a dip buy.

swish30

Earnings winner, wouldn't be surprised if this grinds higher during trading sessions. Entire float traded on Friday though so have to expect volume to start tapering off and with that possible afternoon fades and gap downs on thinner liquidity.

swish30

Seeing a second dead cat bounce here as a volume surge came in midday Friday. This midday action can be profitably faded >50% of the time. Previous dead cat bounce on 2x ADV failed. Suspect this will too. Could see an initial spike on the open would look to short more at the 2.40 mark for a fade down to 1.80ish

swish30

After the insane spike every day trader out there is probably going to put this on watch and attempt to day trade this, and let's be honest, 90% will fail. $7 looks like potential support on a 2-day time period. Lets go for dip-buy there, potential hold overnight into gap up Tuesday.

swish30

Previous FDA winner on new surgical device. Puked after popping now stable. Could see run into earnings here up to 3.70 per share. Note that $50m financing deal is ongoing but this shouldn't have huge impact in the short term.

swish30

This stock has retraced unwarranted hype after contract winner news. Bounced after testing key S/R, now looking for continued slow run up into earnings.

swish30

See commentary on chart. This stock is hyped up, always bought on the open. Waiting for some gap downs to start instigating short positions.

swish30

Flailing whale pattern after earnings (gap up to doji or green doji candle) suggests that the gap level holds (which it has). What I'm looking for now is no gap up but a slow steady push to 23.

swish30

Interestingly had another final hour leg up on 03-Nov which was the pattern observed before the gap and breakout on 02-Nov. Original news has most likely run its course, 14m+ shares been trading with a 5m float. Trying to short here on gap-up for a crack.

swish30

Potentially could test 80-90c if some volume comes in.

swish30

XNET, a huge runner over the past two weeks. #GAP-UP has been a consistently performing trade, however in the last two days #GAP-DOWN has come into the money despite the presence of brutal morning spikes. If shorts get deterred from playing gap-down here, we could see huge potential gap-down profits, ideally a slow and steady decline to hit gap-down profits day...

swish30

Likely that this trades at $11.50 in the near future. Could play potential bounce here but potential data from multiple trials makes this one a bit risky.

swish30

Extremely overbought at current levels after positive news. My potential play here would be scalping a volatile range.